Ā | Ā | All BC cases (nā=ā436) | Families withāā„ā2 BC and/or OC cases (nā=ā273) | Families withāā„ā3 BC and/or OC cases (nā=ā124) | Single affected, diagnosisāā¤ā50Ā years (nā=ā163) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Composite genotype (rs152451-rs45551636) | Controls (%) (nā=ā809) | BC cases (%) | Pvaluea | OR [95% CI] | BC cases (%) | Pvaluea | OR [95% CI] | BC cases (%) | Pvaluea | OR [95% CI] | BC cases (%) | Pvaluea | OR [95% CI] |
A/A-C/C | 674 (83.3%) | 351 (80.5%) | - | 1.0 (ref) | 210 (76.9%) | - | 1.0 (ref) | 88 (71.0%) | 0 | 1.0 (ref) | 141 (86.5%) | - | 1.0 (ref) |
A/G-C/C | 106 (13.1%) | 58 (13.3%) | 0.79 | 1.1 (0.7-1.5) | 43 (15.8%) | 0.18 | 1.3 (0.9-1.9) | 23 (18.6%) | 0.06 | 1.7 (1.0-2.7) | 15 (9.2%) | 0.19 | 0.7 (0.4-1.2) |
A/G-C/T | 21 (2.6%) | 21 (4.8%) | 0.04 | 1.9 (1.0-3.6) | 17 (6.2%) | 0.01 | 2.6 (1.4-5.0) | 10 (8.1%) | 0.003 | 3.6 (1.7-8.0) | 4 (2.5%) | 1.00 | 0.9 (0.3-2.7) |
G/G-C/C | 6 (0.7%) | 4 (0.9%) | 0.74 | 1.3 (0.4-4.6) | 2 (0.7%) | 1.00 | 1.1 (0.2-5.3) | 2 (1.6%) | 0.24 | 2.6 (0.5-12.9) | 2 (1.2%) | 0.63 | 1.6 (0.3-8.0) |
G/G-C/T | 2 (0.2%) | 1 (0.2%) | 1.00 | 1.0 (0.1-10.6) | 0 (0.0%) | - | - | 0 (0.0%) | - | - | 1 (0.6%) | 0.44 | 2.4 (0.22-26) |
G/G-T/T | 0 (0.0%) | 1 (0.2%) | - | - | 1 (0.4%) | - | - | 1 (0.8%) | - | - | 0 (0.0%) | - | - |